Insulin shortage may last until March 2012, Sanofi says

11/17/2011 | (U.K.)

Sanofi has announced that the normal supply of its Apidra insulin may resume around March next year, following a technical glitch the firm has encountered in its manufacturing process in Frankfurt, Germany. Patients on Apidra therapy are advised to switch to a different method or a different brand of insulin.

View Full Article in: (U.K.)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Fort Worth, TX
Director, Senior Legal Counsel
Fort Worth, TX
Corporate Counsel - Healthcare Law Group
South San Francisco, CA
Manager/Senior Manager, Health Services Analytics
Avalere Health
Washington, DC